Literature DB >> 16157720

Applying the 2005 Canadian Hypertension Education Program recommendations: 2. Assessing and reducing global atherosclerotic risk among hypertensive patients.

Brenda R Hemmelgarn1, Steven Grover, Ross D Feldman.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16157720      PMCID： PMC1197156          DOI： 10.1503/cmaj.050185

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.

Authors:  Brenda R Hemmelgarn; Finlay A McAllister; Martin G Myers; Donald W McKay; Peter Bolli; Carl Abbott; Ernesto L Schiffrin; Steven Grover; George Honos; Marcel Lebel; Karen Mann; Thomas Wilson; Brian Penner; Guy Tremblay; Sheldon W Tobe; Ross D Feldman
Journal:  Can J Cardiol       Date:  2005-06       Impact factor: 5.223

2.  Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification.

Authors:  L G Ogden; J He; E Lydick; P K Whelton
Journal:  Hypertension       Date:  2000-02       Impact factor: 10.190

3.  Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

Authors:  Bruce M Psaty; Thomas Lumley; Curt D Furberg; Gina Schellenbaum; Marco Pahor; Michael H Alderman; Noel S Weiss
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

4.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321
  4 in total
  1 in total

Review 1.  Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature.

Authors:  Stacey L Sheridan; Eric Crespo
Journal:  BMC Health Serv Res       Date:  2008-03-20       Impact factor: 2.655
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.